209 related articles for article (PubMed ID: 32990192)
1. Central diabetes insipidus induced by temozolomide: A report of two cases.
Mahiat C; Capes A; Duprez T; Whenham N; Duck L; Labriola L
J Oncol Pharm Pract; 2021 Jun; 27(4):1040-1045. PubMed ID: 32990192
[TBL] [Abstract][Full Text] [Related]
2. Central diabetes insipidus: a previously unreported side effect of temozolomide.
Faje AT; Nachtigall L; Wexler D; Miller KK; Klibanski A; Makimura H
J Clin Endocrinol Metab; 2013 Oct; 98(10):3926-31. PubMed ID: 23928668
[TBL] [Abstract][Full Text] [Related]
3. Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Kuo C; Foon D; Waters K; Cheung C; Margol AS
Pediatr Blood Cancer; 2020 Dec; 67(12):e28516. PubMed ID: 32573959
[No Abstract] [Full Text] [Related]
4. [Central diabetes insipidus: diagnosis and management].
Ballan BK; Hernandez A; Rodriguez EG; Meyer P
Rev Med Suisse; 2012 Nov; 8(362):2158, 2160-4. PubMed ID: 23240316
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
6. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
7. Anti-PD-1 treatment-induced immediate central diabetes insipidus: a case report.
Yu M; Liu L; Shi P; Zhou H; Qian S; Chen K
Immunotherapy; 2021 Oct; 13(15):1255-1260. PubMed ID: 34424037
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
10. Central diabetes insipidus following digestion Solanum indicum L. concentrated solution.
Huang WH; Hsu CW; Fang JT
Clin Toxicol (Phila); 2008 Apr; 46(4):293-6. PubMed ID: 18363121
[TBL] [Abstract][Full Text] [Related]
11. Acute interstitial nephritis and nephrogenic diabetes insipidus following treatment with sulfamethoxazole-trimethoprim and temozolomide.
Athavale A; Morris J; Jardine M; Gallagher M; Sen S; Ritchie A; Wang AY
Nephrology (Carlton); 2021 Jan; 26(1):12-14. PubMed ID: 32935422
[TBL] [Abstract][Full Text] [Related]
12. Long-term hormone replacement treatment in a horse with central diabetes insipidus.
Durie I; van Galen G
J Vet Intern Med; 2020 Mar; 34(2):1013-1017. PubMed ID: 31960998
[TBL] [Abstract][Full Text] [Related]
13. Central diabetes insipidus in five cats: clinical presentation, diagnosis and oral desmopressin therapy.
Aroch I; Mazaki-Tovi M; Shemesh O; Sarfaty H; Segev G
J Feline Med Surg; 2005 Dec; 7(6):333-9. PubMed ID: 15927500
[TBL] [Abstract][Full Text] [Related]
14. 'If there were water we should stop and drink': neurofibromatosis presenting with diabetes insipidus.
Barry R; O' Connor A; Awang MH; O' Toole O
BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440241
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
16. Polyuria and polydipsia in a patient with non-small-cell lung cancer.
Jung JW; Noh GY; Lee TH; Lee YY; Yi KH; Kim CH; Lee JC
Clin Lung Cancer; 2007 Nov; 8(9):565-7. PubMed ID: 18186962
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
18. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
19. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
20. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
